Thymic hyperplasia in Graves′ disease

Thymic hyperplasia in Graves′ disease

Graves′ disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. It is known to be associated with autoimmune conditions such as myasthenia gravis, Addison′s disease, type 1 diabetes mellitus, and vitiligo. We present a case of ra...

Full description

Bibliographic Details
Main Authors:	Narendra Kotwal, Yashpal Singh, Anil Menon, Vineet Behera
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2013-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	Antithyroid drugs autoimmune condition Graves′ disease thymic hyperplasia
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=3;spage=521;epage=523;aulast=Kotwal

Similar Items

Association between thymic hyperplasia and serum calcium level in Graves’ disease
by: Jing Zeng, et al.
Published: (2024-01-01)

Massive Thymic Hyperplasia Masquerading as Cancer: A Case Report and Review of the Literature
by: Emily Stern Gatof, MD, et al.
Published: (2023-02-01)

Indefinite antithyroid drug therapy in toxic Graves′ disease: What are the cons
by: Rajesh Rajput, et al.
Published: (2013-01-01)

Long-term outcomes of graves disease in children treated with anti-thyroid drugs
by: Ya-Ting Chiang, et al.
Published: (2020-06-01)

The treatment of Graves' disease in children and adolescents
by: Hae Sang Lee, et al.
Published: (2014-09-01)

Pharmacological Survey of Graves\' Disease: A Mini Review
by: Akhtar Saifi, et al.
Published: (2021-04-01)

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
by: Mengistu HS, et al.
Published: (2022-04-01)

Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves’ disease and Graves’ ophthalmopathy
by: Tsai Kun-Hsi, et al.
Published: (2012-11-01)

Hyperthyroidism in pregnancy: evidence and hypothesis in fetal programming and development
by: Stine Linding Andersen, et al.
Published: (2021-03-01)

The role of long term use of antithyroid drugs in Graves’ disease
by: SA Abhayaratna, et al.
Published: (2013-05-01)

Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
by: Ari Song, et al.
Published: (2021-06-01)

Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves’ Disease
by: Jia Liu, et al.
Published: (2017-09-01)

Childhood Grave’s-an experience from a tertiary care center
by: Vikrant Ghatnatti, et al.
Published: (2023-08-01)

Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial
by: Lindsay Brammen, et al.
Published: (2018-09-01)

Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves’ disease: a systemic review
by: Qingxing Xie, et al.
Published: (2023-10-01)

Timing of Graves’ Hyperthyroidism Management in Pregnant Women: Impact on the Infant Thyroid Volume
by: Aleksandra Mikołajczak, et al.
Published: (2022-05-01)

Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a case report and literature review
by: Wenfeng Xu, et al.
Published: (2023-09-01)

The coexistence of hypercalcemia, osteoporosis and thymic enlargement in graves’ disease: a case report
by: Dandan Yan, et al.
Published: (2020-06-01)

Elevation of serum creatine kinase during methimazole treatment of Graves disease in a 13-year-old girl and a literature review of similar cases
by: Hyeseon Kim, et al.
Published: (2015-06-01)

Graves' Disease and the Post-partum Period: An Intriguing Relationship
by: Laura Croce, et al.
Published: (2019-12-01)

Massive true thymic hyperplasia with osseous metaplasia
by: Jun Kanzawa, MD, et al.
Published: (2023-06-01)

Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
by: Magdy Mohamed Allam, et al.
Published: (2023-06-01)

Thoracoscopic approach for massive thymic hyperplasia in an infant: Case report and literature review
by: Jinghua Jiao, et al.
Published: (2023-03-01)

Hemodynamic Instability during Thyroidectomy in Graves’ Disease
by: Sami Acar, et al.
Published: (2022-02-01)

Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse
by: Tsz Wai Catherine Wong, et al.
Published: (2022-12-01)

Double sero-negative myasthenia gravis associated with thymic hyperplasia and autoimmune thyroiditis in a young patient
by: Maria-Gabriela Catana, et al.
Published: (2017-06-01)

Rebound Thymic Hyperplasia after Chemotherapy in Children with Lymphoma
by: Chih-Ho Chen, et al.
Published: (2017-04-01)

Antithyroid Drug Treatment in Graves’ Disease
by: Jae Hoon Chung
Published: (2021-06-01)

Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
by: Yoon Young Cho, et al.
Published: (2022-04-01)

A rare case of true thymic hyperplasia in an adult
by: Angus Porter, MD, et al.
Published: (2023-10-01)

Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs
by: Jung Gi Rho, et al.
Published: (2021-12-01)

Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
by: Meihua Jin, et al.
Published: (2023-03-01)

Cat Scratch Disease—A Benign Disease with Thymic Hyperplasia Mimicking Lymphoma
by: Ming Hui Leong, et al.
Published: (2023-07-01)

Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection
by: Lei Qiu, et al.
Published: (2021-01-01)

Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study
by: Eyun Song, et al.
Published: (2021-12-01)

Occurrence of thymic pathology in two families. Is familial screening justified?
by: Sotirios D. Moraitis, et al.
Published: (2018-09-01)

A rare association between true thymic hyperplasia and thyroid follicular tumor: a case report
by: Takumi Kiwaki, et al.
Published: (2020-01-01)

Thymic hyperplasia due to excess growth hormone stimulation: A case report
by: Claire Brookmeyer, MD, et al.
Published: (2022-04-01)

Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset Graves' disease treated with antithyroid drugs
by: Shuo‐Yu Wang, et al.
Published: (2020-04-01)

Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea
by: Hee Kyung Kim, et al.
Published: (2015-12-01)